Our Mission

We’re here to decrease the public health threat from COVID-19 and mitigate the pandemic’s economic impact until a vaccine is widely available. A rapid, reliable, inexpensive and easy-to-use at-home antigen test will significantly reduce virus transmission, particularly by asymptomatic patients, while enabling people with negative results to engage in day-to-day activities – from going to work, going to school, shopping, visiting a relative or vacationing. Widespread use of rapid tests is currently limited by the need for trained clinicians or laboratory equipment to ensure that tests are performed and interpreted accurately, the Gauss Rapid At-Home Test can be performed in 15 minutes by an individual, in any location, with a smartphone. Please note, this technology is currently investigational and not authorized or approved by FDA.

What’s inside

The Gauss️ COVID-19 Test Kit includes all the materials necessary to self-administer the test:
a nasal swab, tube with stand, buffer solution, test cassette, a quick guide, and instructions for use.
The smartphone app reads the test results for you, so no additional equipment is needed.

Test Cassette

Nasal Swab

Tube with Stand

Buffer Solution

Quick Guide

How does it work?

Users follow simple step-by-step video instructions in an app to properly collect a nasal swab and complete the rapid test. After 15 minutes, the app prompts the user to scan their test and uses patent-pending, computer vision and artificial intelligence (AI) technology to provide results in seconds. The HIPAA-compliant app securely shares results with the appropriate public health agencies.

In a prospective clinical trial of 219 symptomatic and asymptomatic individuals submitted to the FDA in support of our EUA application, the Gauss Rapid Test demonstrated a 93% Positive Percent Agreement (PPA) and 99% Negative Percent Agreement (NPA) compared to a high-sensitivity, EUA-authorized RT-PCR molecular assay.

QR Scan to Activate

Guided Nasal Swab Collection

Rapid Test Scan

Results in 15 minutes

Sound Interesting?

The Gauss Rapid Antigen Home Test will be made available through various partners and channels, as well as directly from Gauss. Contact us to learn more about partnering with Gauss. This test is currently pending Emergency Use Authorization (EUA) from FDA. The Gauss app is available on the Apple App Store and is already being used by research teams at large academic medical centers to power large-scale, at-home research studies on COVID-19.

Frequent Questions

Antigens are a part of SARS-CoV-2, the virus that causes COVID-19. This test tells you if you have a detectable amount of SARS-CoV-2 Nucleocapsid “N” antigen in your nasal passage. It is meant to determine if you have COVID-19 and have a high risk of transmitting it to others. It is possible to be infected with COVID-19 and have a negative rapid test. Usually, this means you may have a mild (or early) infection and cannot currently pass on your infection to other people.
There is a growing consensus among public health experts, governmental agencies, and business leaders that widely-accessible rapid, self-administered home testing is needed to decrease the public health threat from COVID-19 as vaccines become more widely available. Rapid, reliable, inexpensive and consumer-friendly at-home testing can significantly reduce virus transmission, particularly by asymptomatic and pre-symptomatic patients, while enabling people with negative results to engage in their day-to-day activities – from going to work, going to school, shopping, visiting a relative or vacationing – while decreasing the risk of transmission.
Users follow simple step-by-step video instructions in an app to properly collect a nasal swab and complete the rapid test. After 15 minutes, the app prompts the user to scan their test and uses patent-pending, computer vision and artificial intelligence (AI) technology to provide results in seconds. The HIPAA-compliant app securely shares results with the appropriate public health agencies.
A smartphone (iOS or Android) is required to perform the Gauss COVID-19 rapid antigen test at home. The Gauss test kit includes all the materials necessary to perform the test and the free smartphone app allows users to read the test, so no additional instrument or equipment is necessary.
In a prospective clinical trial of 219 symptomatic and asymptomatic individuals submitted to the FDA in support of our EUA application, the Gauss Rapid Test demonstrated a 93% Positive Percent Agreement (PPA) and 99% Negative Percent Agreement (NPA) compared to a high-sensitivity, EUA-authorized RT-PCR molecular assay.

Users will be able to scan their test with their smartphone camera about 15 minutes after taking the nasal swab sample and activating the test. The app will then indicate the test result within seconds.

The Gauss at-home rapid antigen test is a screening/diagnostic tool that requires US FDA Emergency Use Authorization (EUA). Gauss’s EUA application was submitted to FDA in late Fall 2020 and is currently under review. Please stay tuned for more information on how to order the test following Emergency Use Authorization.

The Gauss at-home rapid antigen test is currently pending Emergency Use Authorization from the FDA. Once authorized, it will be made available through partners such as Kroger Health, Ro, Truepill, as well as directly from Gauss online. Please stay tuned for more information on how to order the test following FDA EUA.

We are engaging with select partners whom we believe will help us making rapid, affordable testing as widely and responsibly available to Americans as possible through established D2C pharmacy, telemedicine, retail, and/or home delivery channels. Please send us an indication of interest by submitting your email and a message below, and we’ll be happy to reach out and discuss in greater detail. You can also email us directly at partners@gauss.com.
If you are interested in bringing rapid testing to your organization, please send us an indication of interest by submitting your email and a message below, and we’ll be happy to reach out and discuss in greater detail. You can also email us directly at enterprise@gauss.com.